<DOC>
	<DOCNO>NCT00991276</DOCNO>
	<brief_summary>The purpose study assess efficacy safety pregabalin pramipexole versus placebo treatment restless legs syndrome associate sleep disturbance .</brief_summary>
	<brief_title>Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Diagnosis restless legs syndrome total score 15 point International RLS rating scale ( IRLS ) . RLS symptoms interfere sleep 3 night per week least 6 month . PSG confirmation WASO least 60 min , PLMI 10 , total sleep time least 3 hr less 6.5 hr . Secondary RLS . Daytime RLS symptom require treatment . Primary sleep disorder . Sleep apnea . Night shift work . Concurrent medical disorder could interfere efficacy assessment present safety concern . Pregnant lactate woman . Women childbearing potential use acceptable method birth control . Use prohibit medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>restless legs syndrome RLS polysomnography PSG sleep disturbance patient report outcome</keyword>
</DOC>